Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy

NCT04534439 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDIV

Sponsor class

Conditions

Diabetic Nephropathies
Diabetes Mellitus, Type 2
Nephropathy, Diabetic

Interventions

DRUG: APX-115
DRUG: Placebo

Sponsor

Aptabio Therapeutics, Inc.